Innovation-led Indian healthcare market to hit $320 bn by FY28: Bain
The innovation segment is dominated by pharma services (CDMO, CRO, pharma IT) and health-tech with vaccines and biotech, and med-tech emerging as green shoots
vaccines
March 2024
March 2022
February 2022
Wockhardt forays big into Covid-19 vaccines
Wockhardt and Serum Life Sciences UK will make a new sterile fill and finish facility in Wrexham, North Wales in the UK.
Vaccines, Biologics: Indian Pharma’s New Temptations
API, diagnostics, New Chemical Entity — Covid has thrown up new opportunities, and domestic pharma biggies are charging in with renewed focus.
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
Resurgence of interest and new technologies bring a huge opportunity for the vaccine development field, says Biocon CMD Kiran Mazumdar-Shaw.
